Executive Chair
NeuWire Medical

Position Location
Remote

Company Headquarters
Plano, Texas

Technology
Neuromodulation

Company Size
1-10 Employees

Position Overview

NeuWire Medical is a Dallas-based neuromodulation startup developing the world’s smallest wireless, closed-loop, vagus nerve stimulation (VNS) technology. Having completed 4 randomized control trials (RCT), NeuWire Medical received breakthrough device designation for its stork indication. NeuWire Medical is a technology spin out of Xnerve Medical and is hiring an Executive Chair in preparation for its Pivotal IDE.

Publication: Spin Out Article

We have partnered with Rob Rennaker, Co-Founder & Acting CEO, along with the Board of Directors of NeuWire to appoint an Executive Chair who will work closely with leadership to accelerate fundraising, guide the company through clinical trials, and develop strategic partnerships.

NeuWire Medical is looking for an Executive Chair who has previous experience as a MedTech CEO having raised funding of more than $15M in a single round and ideally has experience working with medical devices in the neuro space.

With your relevant experience as a MedTech Board Chair, I am sharing this opportunity with you to review, network, and explore. Please let me know if you have interest in discussing further.

Responsibilities

Own the hardware roadmap in partnership with the CTO: define technical direction, make build-vs-buy calls, and sequence milestones that align with business goals.
Design and ship boards: schematic capture, stack-up definition, layout, simulation, bring-up, and verification for analog/RF, power, and mixed-signal systems.
Sustain and improve the current line: execute EOL component substitutions, cost and yield improvements, and DFx (DFM/DFT/DFR) updates; drive ECOs cleanly through release.
Lead design transfer: prepare complete manufacturing packages (BOMs, drawings, Gerbers, test procedures), resolve build issues with EMS/CM partners, and close PPAP/FAI as needed.
Build manufacturing & service tooling: design fixtures, test harnesses, and simple automation to improve throughput, repeatability, and field diagnostics.
Debug fast and well: triage service and user issues, perform root-cause analysis across hardware/firmware/system boundaries, and land corrective actions that stick.
Design within a QMS: contribute requirements, risk analyses, verification plans, test reports, and traceability; maintain a tidy Design History File.
Own compliance paths: plan and execute EMC/safety pre-compliance, coordinate with test labs, and bake compliance into design constraints early.
Collaborate and mentor: set hardware best practices, review peer designs, and help grow a small, high-leverage team over time.

Qualifications & Competencies

5+ years of hardware product development with shipped boards in production.
BS in Electrical or Computer Engineering (MS/PhD preferred).
Analog and RF experience, including simulation and layout (e.g., LNAs/AFEs, filters, impedance control, shielding/grounding, EMC-aware design).
Proficiency with EDA & simulation tools, ideally Altium Designer plus SPICE/ADS (or equivalent).
Demonstrated design transfer experience and DFM for volume builds; comfortable working with EMS/CMs.
Experience working within a QMS (creating/using design controls, verification/validation, ECOs, documentation discipline).
Strong bench skills: scopes, VNAs/SAs, SMUs, logic analyzers; methodical bring-up and debug.
Clear written and verbal communication; ability to drive decisions across disciplines.

Company Overview

NeuraSignal is transforming stroke care with real-time access to cerebral blood flow—empowering clinicians to detect and prevent strokes with speed, accuracy, and automation.

At the core of our mission is a bold belief: Eliminating stroke begins with real-time brain data, accessible to any provider, anywhere. Powered by AI and robotics, our flagship platform—NovaGuide 2 (NG2)—delivers hands-free, autonomous transcranial Doppler (TCD) exams for the detection of right-to-left shunts (RLS), emboli, and cerebral vasospasm.

Why it matters: up to 30% of strokes are cryptogenic, and traditional tools like TTE miss most PFOs. NG2 detects 3x more PFOs than standard echo and identifies 2.7x more treatable shunts, giving clinicians the clarity to act—and patients the chance to prevent a second stroke.

Fully reimbursable under existing CPT codes (93886, 93892, 93893), NG2 brings diagnostic-grade neurovascular imaging to hospitals, ASCs, stroke centers, and rural clinics—without relying on specialized techs.

Anteris Technologies Team